Manna Temesvári

Summary

Affiliation: Chemical Research Center
Country: Hungary

Publications

  1. doi request reprint Drug interaction potential of 2-((3,4-dichlorophenethyl)(propyl)amino)-1-(pyridin-3-yl)ethanol (LK-935), the novel nonstatin-type cholesterol-lowering agent
    Katalin Monostory
    Chemical Research Center, Hungarian Academy of Sciences, Budapest, Hungary
    Drug Metab Dispos 37:375-85. 2009
  2. doi request reprint High-resolution melting curve analysis to establish CYP2C19∗2 single nucleotide polymorphism: Comparison with hydrolysis SNP analysis
    Manna Temesvári
    Chemical Research Center, Hungarian Academy of Sciences, Pusztaszeri 59 67, H 1025 Budapest, Hungary
    Mol Cell Probes 25:130-3. 2011
  3. doi request reprint Estimation of drug-metabolizing capacity by cytochrome P450 genotyping and expression
    Manna Temesvári
    Research Center for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary
    J Pharmacol Exp Ther 341:294-305. 2012

Detail Information

Publications3

  1. doi request reprint Drug interaction potential of 2-((3,4-dichlorophenethyl)(propyl)amino)-1-(pyridin-3-yl)ethanol (LK-935), the novel nonstatin-type cholesterol-lowering agent
    Katalin Monostory
    Chemical Research Center, Hungarian Academy of Sciences, Budapest, Hungary
    Drug Metab Dispos 37:375-85. 2009
    ....
  2. doi request reprint High-resolution melting curve analysis to establish CYP2C19∗2 single nucleotide polymorphism: Comparison with hydrolysis SNP analysis
    Manna Temesvári
    Chemical Research Center, Hungarian Academy of Sciences, Pusztaszeri 59 67, H 1025 Budapest, Hungary
    Mol Cell Probes 25:130-3. 2011
    ..However, the HRM analysis was found to be more efficient, rapid, user- and cost-friendly method...
  3. doi request reprint Estimation of drug-metabolizing capacity by cytochrome P450 genotyping and expression
    Manna Temesvári
    Research Center for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary
    J Pharmacol Exp Ther 341:294-305. 2012
    ..Patients' genetic and nongenetic variations in P450 status can guide the appropriate selection of drugs and the optimal dose, minimizing the risk of harmful side effects and ensuring a successful outcome of drug therapy...